Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil Minimal Effective Dose for Laryngeal Mask Insertion in Children
ChiCTR2400080027Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of sufentanil in perioperative pain, sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: 50% minimum effective concentration of sufentanil, 90% minimum effective concentration of sufentanil and 2 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
sufentanil
03
Conditions
perioperative pain
Beyond the preview
Go deeper on ChiCTR2400080027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080027.